key: cord-1038659-id3ohjop authors: Vallis, Michael; Glazer, Stephen title: Protecting individuals living with overweight and obesity: Attitudes and concerns toward COVID‐19 vaccination in Canada date: 2021-06-23 journal: Obesity (Silver Spring) DOI: 10.1002/oby.23182 sha: 022eb2bbb9f44e559617cb8bbd34bcdf811de460 doc_id: 1038659 cord_uid: id3ohjop OBJECTIVE: The aim of this study was to assess attitudes toward coronavirus disease 2019 (COVID‐19) vaccination and the degree of fear of COVID‐19 among those living with obesity. METHODS: Two samples were recruited for an online survey: one sample was a representative sample of Canadians living with overweight and obesity (n = 1,089), and the second was a convenience sample of individuals recruited from obesity clinical services or patient organizations (n = 980). Respondents completed ratings of their comfort receiving a COVID‐19 vaccination along with the Vaccine Hesitancy Scale and the Fear of COVID‐19 Scale. RESULTS: Approximately one‐third of respondents, regardless of sample or weight category, were not comfortable receiving a vaccination, and one‐half expressed moderate or greater perceived risks of vaccination. Confidence in vaccinations was extremely low, especially for those in the clinical sample. Fear of COVID‐19 was substantial and predicted attitudes toward vaccination. Females were less comfortable receiving the vaccine and perceived more risks than males. CONCLUSIONS: These results suggest those living with obesity are highly ambivalent about COVID‐19 vaccination. Despite their being at high risk, their confidence in vaccines is very low. Results suggest the need for patient‐centered counseling, with a focus on shared decision‐making to strengthen confidence and reduce perceived risk. VACCINE HESITANCY AMONG PERSONS WITH OBESITY perception, the Fear of COVID-19 (FCV) Scale (10) has recently been developed but has not been used specifically in persons with obesity. Now that vaccines against COVID-19 have been developed, the task is to distribute them globally. However, in order for a vaccination program to control the virus by herd immunity, it is necessary to have a safe and effective vaccine administered to at least 75% to 85% of the population (11) . However, the uptake of vaccination is dependent on the attitudes and concerns of the individual. As such, vaccination is a behavioral issue. The consequence of a delay in vaccination has been seen with other viruses, where there is regional clustering of infections from measles, mumps, and diphtheria (12, 13) . Vaccine hesitancy has become a significant public health concern. The World Health Organization -Strategic Advisory Group of Experts on Immunization (WHO-SAGE) standardized a scale measuring vaccine attitudes (14, 15) . The Vaccine Hesitancy Scale (VHS) assesses confidence in vaccines as well as perceived risks (16) . This scale was initially developed to assess parents' attitudes toward vaccinating their children but was adapted to assess personal attitudes toward vaccination (17) . In an attempt to understand the psychosocial and behavioral impact of the COVID-19 pandemic on individuals living with overweight and obesity, we recently completed a survey-based study called EPOCH: Evaluation of the Pandemic on Obesity Care and Health. The EPOCH survey included a broad assessment of the impact of the pandemic on behavior, emotions, and psychosocial functioning of those living with overweight and obesity. Of specific relevance to this paper, we included questions assessing comfort level in receiving a COVID-19 vaccine, the VHS and the FCV Scale. This paper reports on the results of these measures in those living with overweight and obesity. Given the timeliness of understanding attitudes toward vaccines, we decided to publish this subset of data independent from the entire data collected. Our main questions in this paper include the following: • How comfortable are individuals living with obesity in receiving a COVID-19 vaccine? • How confident are individuals living with obesity in vaccine programs in general, and what level of risk do they perceive? • How common are fears of COVID- 19? • To what extent does degree of obesity (overweight, class 1 obesity, class 2 obesity, class 3 obesity) impact attitudes toward vaccination? • What are the correlates of vaccine hesitancy? For this question, we considered selected demographic behavioral and psychological factors. The EPOCH survey (English only, June 22 to October 9, 2020) was conducted online and involved 2 samples. First, the survey was disseminated widely to medically supervised participants of obesity clinics and organizations throughout Canada and abroad (see online Supporting Information for details). We refer to these respondents as our clinical sample. Second, a survey company (Inet International, Thornhill, Ontario) collected responses from a representative sample of ~1,000 Canadians living with overweight or obesity. We refer to these respondents as our survey sample. This paper focuses specifically on attitudes and concerns about potential vaccination against COVID-19. The following measures were part of the EPOCH survey and were completed by all respondents. First, respondents were asked to rate their degree of agreement (using a 7-point Likert scale) with the following 2 statements: "To what extent would you feel comfortable receiving a vaccine against COVID-19 if it became available?" and "To what extent would you feel comfortable giving your children a vaccine against COVID-19 if it became available?" Items were written such that the responses ranged from "Not at all" (1), through "Moderately" (4), to "Extremely" (7). ► Obesity is a risk factor for hospitalization, intensive care unit admission, and mortality from coronavirus disease 2019 (COVID-19). ► Vaccines have been developed to combat COVID-19 but are dependent on acceptance by the population; hence, vaccine attitudes and fear play a strong role in achieving herd immunity. ► Approximately 40% of those living with obesity were not comfortable receiving a COVID-19 vaccination. ► In the context of significant fear of COVID-19, especially for those in higher weight categories, confidence in vaccination programs was very low, especially in those pursuing obesity management. ► In light of the significant ambivalence concerning COVID-19 vaccination among those living with obesity, significant attention should be placed on communication skills promoting shared decision-making to reduce ambivalence and build trust in medical recommendations. Two validated scales were also administered: 1. VHS (17) : This scale has 9 items that compose 2 subscales: Confidence in Vaccines (7 items) and Perceived Risks of Vaccines (2 items). Responses were coded on a 7-point Likert scale. Items were written such that the responses ranged from "Not at all" (1), through "Moderately" (4), to "Extremely" (7) . We replicated a factor analysis based on this 7-point ranking and verified the original 2-factor structure (Cronbach α = 0.96 for Confidence subscale; 0.68 for the Perceived Risks subscale). 2. FCV Scale (10): This 7-item rating scale was shown to be reliable and have good construct validity, with a single factor. Unlike the other scales, these items were rated on a 5-point Likert scale, to preserve the format of the validated scale. Items were written such that the responses ranged from "Strongly disagree" (1), through "Neither agree or disagree" (3), to "Strongly agree" (5). Using our data, we confirmed strong internal consistency of this measure (Cronbach α = 0.87). A factor analysis revealed 2 factors, in contrast to the original paper. Descriptive analyses were used to describe the main results. Mean scores on the subscales of the VHS and the FCV Scale as well as the 2 specific questions assessing comfort receiving the COVID-19 vaccine were reported and compared using within-subjects ANOVA. Percentage responses to the items were also calculated where appropriate. Our sample size was sufficient to allow for a comparison between the survey-based and clinical samples as well as the category of weight (overweight, class 1 obesity, class 2 obesity, and class 3 obesity). These comparisons were conducted using a 2-factor ANOVA, with one 2 level factor (survey and clinical) and one 4 level factor (overweight, class 1 obesity, class 2 obesity, class 3 obesity). Finally, we conducted a regression analysis to explore correlates for vaccine hesitancy. Separate regression equations were calculated for the Confidence and Perceived Risks subscales of the VHS and also for the rating of degree of comfort receiving a COVID-19 vaccination. For each regression equation, we conducted a stepwise analysis. Demographic factors were entered as step 1, then behavioral factors were entered as step 2, and finally, psychological factors were entered as step 3 in the analysis. A full analysis of the EPOCH survey database will be published elsewhere. A total of 2,078 respondents completed the survey. Of these, 1 Detailed analyses of the demographic data will be published in a separate paper. Nonetheless, it is notable that there were strong differences between the samples. The clinical sample was heavier than the survey sample, with almost 50% of the sample having BMI above 40 and more than 70% of the sample having BMI above 35 (only ~35% of the survey sample had BMI above 35). Expectedly, the clinical sample was primarily female (82.5%), whereas the survey sample was balanced (50.2% female). In addition, almost none of the survey sample had undergone bariatric surgery, whereas more than 20% of the clinical sample had had bariatric surgery, and another 20% were awaiting or considering surgery. Although we attempted to recruit an international sample of clinical respondents, only 3.8% were from the US and 1.2% from other countries. Figure 1A portrays the data on level of comfort to receive a COVID-19 vaccination as well as on the 2 subscales of the VHS. On average, respondents were moderately comfortable receiving a COVID-19 vaccination and more comfortable receiving the vaccine themselves than with their child receiving the vaccine (p < 0.001). Strikingly, the mean score on the Confidence subscale of the VHS was very low, significantly lower than any other measure. Furthermore, Perceived Risks scores were in the low to moderate range (higher than the Confidence subscale, p < 0.001, but lower than the COVID-19 scales, all p < 0.001). The results from the FCV Scale are shown in Figure 3 . Mean scores were generally low to moderate for each item and the mean of the scale. However, the score on the item "I am afraid of COVID-19" was elevated. On this item, 65.2% of respondents reported either "Agree" or "Strongly agree." In addition, a substantial proportion of respondents reported "Agree" or "Strongly agree" with the following items: "It makes me uncomfortable to think about COVID-19" Comparisons based on the factor scores are presented in Given that EPOCH was a broad survey of the experience of the pandemic by those living with overweight and obesity, we collected a number of additional measures beyond those focusing on vaccination and fear of the virus. We selected specific demographic, behavioral, and mental health factors to examine how they relate to vaccine attitudes. Regarding demographic factors, we included age, Specifically, we entered demographic factors on step 1, behavioral factors on step 2, and mental health factors on step 3. We report on the significance and percentage of variance accounted for at each step of the regression and also report the Beta weight and p values of any significant predictor at that step. Results are shown in Table 1 . Regarding being comfortable receiving a COVID-19 vaccination, females were more comfortable than males, as were those with comorbidities. Those less likely to follow social distancing were more comfortable receiving the COVID-19 vaccination, as were those who obtained a flu vaccination. Finally, those with higher scores on the CES-D depression screening scale were less comfortable receiving the COVID-19 vaccination. Next, considering the Confidence in Vaccines subscale, those with comorbidities had lower confidence scores. Those who resist social distancing rules scored higher on the Confidence subscale, and those who received a flu vaccination scored lower on the Confidence subscale. Those reporting increased cannabis use during the pandemic reported higher Confidence scores. Finally, those with higher depression scores reported greater Confidence scores. Finally, considering the Perceived Risks of Vaccines subscale, females reported higher risks, as did those with a greater number of people in their household. Those less likely to social distance had higher risk scores, as did those who did not receive a flu vaccination. Those who struggled with healthy behaviors, such as increased smoking, increased cannabis use, and increased challenges in eating healthy, also scored higher on the Perceived Risks subscale. subscales. C1, class 1 obesity; C2, class 2 obesity; C3, class 3 obesity; OW, overweight. With the availability of a COVID-19 vaccination program, vaccine attitudes have become critical. Recent general population surveys have suggested that many people are reluctant to be vaccinated. In the US, 25% to 50% of Americans were willing to accept a vaccination against COVID-19 when available (20, 21) . Data from Statistics Canada in June 2020 revealed that 57.5% of Canadians were very likely to obtain a COVID-19 vaccine when available, and an additional 19.0% were somewhat likely to get vaccinated. Approximately 5.1% were somewhat unlikely, 9.0% were very unlikely, and 9.4% remained unsure whether they would accept a COVID-19 vaccination when available (22) . An Angus Reid poll published on December 14, 2020, revealed that 48% of Canadians would receive a vaccination as soon as available, 31% would accept a vaccine after a wait, 14% would not accept a vaccine, and 7% remained unsure (23) . Attitudes among those living with obesity are particularly important to understand, because obesity is a significant risk factor for poorer COVID-19 outcomes and is associated with conditions that themselves are independent risk factors for severe COVID-19 (24) (25) (26) (27) . Our survey results from those living with overweight and obesity are striking. Approximately one-third (34.5%) reported low comfort in receiving the COVID-19 vaccination, with lower comfort ratings regarding having one's child vaccinated. These results were independent of degree of obesity or of being a survey or clinical respondent. Comfort levels were positively associated with being male, having more comorbidities, having lower depression scores, as well as not practicing social distancing and past acceptance of flu vaccinations. These results require replication but suggest that specific subgroups (e.g., females, those with no comorbidities or avoiding flu vaccinations, or those in emotional distress) might benefit from counseling based on communication and shared decision-making interventions. Although we intended to recruit a multinational sample of clinical respondents, we were not successful, recruiting only 3.8% of respondents from the US. In a post hoc analysis comparing the mean comfort score for receiving a vaccine between the US and Canadian respondents, the US sample was more confident (mean = 5.84) compared with the Canadian sample (mean = 5.04, p < 0.016). One needs to be cautious in interpreting this difference because of the small sample size, but this finding might suggest regional differences in vaccine attitudes. Integral to the success of a vaccination program is one's confidence related to a vaccine. In our survey, confidence in vaccinations in general was extremely low, including perceived vaccine efficacy, their role in preserving good health, trust in government vaccination programs, and confidence in their health care practitioners' recommendations. These may be challenging attitudes to alter and again suggest the need for effective communication interventions. Respondents participating in clinical obesity management programs were less confident in vaccinations than the general survey respondents. This may reflect greater skepticism or disillusionment related to the weight bias experienced from the medical system by most individuals with obesity (28) . It may be that a certain level of trust is required in this rapidly changing pandemic and that these respondents are less trusting relative to the survey sample. Further research attempting to understand the drivers of vaccine confidence is needed. Respondents with higher physiologic COVID-19 fear response, those with no comorbidities, those who were less likely to social distance, those who avoided a flu vaccination, and those who reported higher levels of depression and substance use reported greater confidence, although overall confidence scores were still low. These results clearly indicate a need for communication strategies that assess confidence, identify drivers of low confidence, and encourage cognitive reframing using shared decision-making. Risk perception is also an integral aspect of vaccination attitudes. More than 50% of our respondents considered newer vaccines less safe and to carry more serious risks than older vaccines. Perceived risk was associated with avoidance of flu vaccination, substance use, and less social distancing. Women and those who struggled with healthy eating also reported higher perceived risk. At least 65% of all respondents acknowledged moderate to se- Clearly, further research is needed to better understand the relationships between fear and intentions. Considering the results of this survey, it is critical to obtain a ful- Limitations of the study include that it is a single-time crosssectional assessment during the first wave of the pandemic. All of the scales reported in this paper were administered as part of EPOCH between June 22 and October 9, 2020. We are unable to comment on changes in attitudes and concerns over time. In addition, when the survey was undertaken, availability of the vaccine was not yet accessible. Now that vaccines are currently available, vaccine fears and attitudes may be further affected as well. In addition, the vast majority of data (including all of the survey respondents) are Canadian, so global generalization is not possible. Finally, we did not include a comparison sample of individuals not living with obesity. However, general survey results reported in the media suggest that the general population is more receptive to vaccination than those living with obesity, particularly those representative of the clinical sample. Among the strengths of this study are the fact that we sampled both the general population as well as those seeking help for obesity. Further, our sample size is very large, and we have strong representation from those in the high-BMI category groups. Furthermore, we used validated measurement instruments in an attempt to increase the veracity of the self-reported data. The COVID-19 pandemic has had devastating consequences worldwide for so many individuals. Those living with overweight and obesity are at significantly increased risk for worse outcomes, We would like to acknowledge our medical colleagues who promoted the study within their clinical services. We would also like to acknowledge the respondents, who willingly completed this extensive survey. The authors declared no conflict of interest. MV and SG jointly designed this survey. SG obtained funding for the survey and solicited input from clinical services and organization for recruitment. MV conducted the data analysis and prepared the first draft of the manuscript. MV and SG edited the manuscript and approved the manuscript for publication. Michael Vallis https://orcid.org/0000-0002-0165-5936 Prospective Studies Collaboration Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission Rising rural body-mass index is the main driver of the global obesity epidemic in adults Trends in adult bodymass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults Prevalence of obesity and severe obesity among adults: United States Health characteristics, annual estimates Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships The Fear of COVID-19 scale: development and initial validation Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination The social value of vaccination programs: beyond cost-effectiveness Europe steps up action against vaccine hesitancy as measles outbreaks continue Could the United States experience rubella outbreaks as a result of vaccine refusal and disease importation? Vaccine hesitancy: definition, scope and determinants Measuring vaccine hesitancy: the development of a survey tool Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument A brief measure for assessing generalized anxiety disorder: the GAD-7 The CES-D scale: a self-report depression scale for research in the general population Half of Americans would get a COVID-19 vaccine, AP-NORC poll finds. NBC News Correlates and disparities of intention to vaccinate against COVID-19 Canadians' willingness to get a COVID-19 vaccine when one becomes available: what role does trust play More Canadians willing to roll up their sleeves right away as national COVID-19 vaccine rollout begins Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center study Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study The stigma of obesity: a review and update Severe obesity as an independent risk factor for COVID-19 mortality in hospitalized patients younger than 50 Obesity is a risk factor for severe COVID-19 infection COVID-19 vaccine hesitancy and resistance: correlates in a nationally representative longitudinal survey of the Australian population